Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Victoria Lane Thomas, M.D.

Concepts (54)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Civil Rights120091320.310 Why?
Adrenergic beta-2 Receptor Agonists320161040.280 Why?
Physician's Role120099430.200 Why?
Particle Size2201616390.200 Why?
Disabled Persons1200912070.170 Why?
Adrenal Cortex Hormones3201618330.160 Why?
Anti-Asthmatic Agents220165330.120 Why?
Asthma3201659500.110 Why?
Microspheres120157780.110 Why?
Health Services Accessibility1200951280.100 Why?
Adrenergic beta-Antagonists1201612380.090 Why?
Administration, Inhalation3201610990.080 Why?
Supreme Court Decisions120091260.080 Why?
Glucocorticoids1201521000.070 Why?
Prejudice120095720.060 Why?
Stroke Volume1201649410.060 Why?
Heart Failure22016107930.050 Why?
Pulmonary Disease, Chronic Obstructive1201630290.050 Why?
Disability Evaluation1200918240.050 Why?
Beclomethasone12016380.040 Why?
Pregnenediones12016290.040 Why?
Databases, Factual3201676900.040 Why?
Muscarinic Antagonists120161360.030 Why?
Drug Therapy, Combination2201664780.030 Why?
Drug Utilization Review120162450.030 Why?
Drug Dosage Calculations120151130.030 Why?
Polypharmacy120162900.030 Why?
Bronchodilator Agents120165030.030 Why?
Delayed-Action Preparations120159620.030 Why?
Netherlands1201621690.020 Why?
Angiotensin Receptor Antagonists120169190.020 Why?
Comparative Effectiveness Research120156790.020 Why?
Angiotensin-Converting Enzyme Inhibitors1201615100.020 Why?
Cohort Studies32016403890.020 Why?
Guideline Adherence1201622610.020 Why?
Dose-Response Relationship, Drug12015109450.010 Why?
Logistic Models12016134020.010 Why?
United States12009695730.010 Why?
Primary Health Care1201645370.010 Why?
Treatment Outcome22016626930.010 Why?
Practice Guidelines as Topic1201672740.010 Why?
Disease Progression12015132370.010 Why?
Humans520167393980.010 Why?
Male420163490220.010 Why?
Female420163788530.010 Why?
Time Factors12016400500.010 Why?
Follow-Up Studies12015389420.010 Why?
Child, Preschool12015408020.010 Why?
Middle Aged220162128630.010 Why?
Adult220162133940.010 Why?
Aged, 80 and over12016576500.010 Why?
Retrospective Studies12016766310.000 Why?
Child12015770330.000 Why?
Aged120161626980.000 Why?
Thomas's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (54)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.